egfr therapy as upfront colorectal cancer treatment
Published 8 years ago • 148 plays • Length 5:09Download video MP4
Download video MP3
Similar videos
-
7:10
upfront egfr therapy in metastatic colorectal cancer
-
6:04
upfront treatment of unresectable ras wild-type metastatic colorectal cancer
-
1:33
acquired resistance to anti-egfr therapy in colorectal cancer
-
4:56
upfront bevacizumab and cetuximab compared in metastatic colorectal cancer
-
4:00
optimizing treatment with egfr inhibitors in colorectal cancer
-
7:42
egfr-targeted therapy in metastatic colorectal cancer
-
16:30
up-front treatment in egfr wild-type patients
-
5:30
treatment options for advanced colorectal cancer
-
2:10
anti-egfr therapy for ras wild-type left-sided colorectal cancer
-
0:42
dr. fakih on anti-angiogenesis versus anti-egfr therapy in colon cancer
-
16:56
colorectal cancer with acquired resistance to egfr antibodies: how to manage?
-
7:32
considerations when selecting an egfr inhibitor in metastatic colorectal cancer
-
13:46
choosing between anti-vegf and anti-egfr targeted therapy
-
13:46
choosing between vegf and egfr targeted therapy in mcrc
-
1:50
dr. benson on sequencing strategies with cetuximab in crc
-
1:35
dr. eng on the treatment landscape in metastatic colorectal cancer
-
3:48
mechanisms of resistance to upfront egfr-targeted therapy
-
1:12
targeted therapies in metastatic colorectal cancer
-
2:38
metastatic colorectal cancer: frontline treatment paradigm